Investing
1490 Articles
Next week will mark the third week of the full daily earnings onslaught in what is really the fourth week…
The drug sector has become rather boring and investors already know all about the ongoing patent expiration threats that loom…
The Fed’s exit from QE2 may involve rate increases (Reuters) Deutsche Bank will restructure its US bank business to avoid…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday…
Republicans plan to cut $6 trillion from the budget over the next decade (Reuters) Google (NASDAQ: GOOG) may be investigated…
David Sokol’s trading in Lubrizol before Berkshire Hathaway (NYSE: BRK) bought it may cause regulators to review the transaction. (Reuters)…
America lost its lead as the world’s top manufacturer to China. That is in part the basis of the argument…
It is time for “The Daily Dividend” and we have an interesting call ahead. How long has it been that…
It’s the BioHeath Daily for key developments in drugs, biotech, and medical developments. Prana Biotechnology Ltd. (NASDAQ: PRAN) is often…
Many shareholders argue that share repurchase and stock buyback plans are generally a waste of shareholder capital aimed solely as…
The method of using capital from the corporate treasury to return capital to shareholders via share repurchase programs has long…
Economists cheered the ADP data that showed the private sector added 187,000 jobs in January. It did not help the…
These are some of this Wednesday’s top analyst calls with upgrades, downgrades, and initiations seen from Wall Street research firms.…
These are some of this Monday’s top analyst calls with upgrades, downgrades, and initiations seen from Wall Street research firms.…
Our top personal finance-related articles today. Your wallet will thank you later.